Answers are grounded in this paper and cite their sources.
Our previous studies have shown that Huanglian Jiedu Decoction effectively suppresses central immune-inflammatory responses, modulates peripheral inflammatory mediators, reduces the infiltration of peripheral T lymphocytes into the central nervous system, and promotes the conversion of infiltrated T lymphocytes in the brain into Treg cells. However, whether Huanglian Jiedu Decoction can influence M2 microglial polarization by regulating T-lymphocyte phenotypic transformation and thereby modulate neuroinflammation after ischemic stroke remains unclear. This study focused on Treg-mediated microglial polarization to investigate the potential of Huanglian Jiedu Decoction to modulate interactions between T lymphocytes and microglia in the treatment of ischemic stroke. We established a rat model of middle cerebral artery occlusion, an inflammatory model of Jurkat T cells stimulated with phorbol 12-myristate 13-acetate and ionomycin, and a Transwell co-culture model of T lymphocytes and HMC3 microglia. The results showed that Huanglian Jiedu Decoction effectively alleviated cerebral ischemia-reperfusion injury in a rat model of middle cerebral artery, inhibited central inflammatory responses, and promoted the polarization of microglia toward the M2 phenotype. Huanglian Jiedu Decoction also promoted the conversion of CD4+ T cells in brain tissue into regulatory T cells and regulated regulatory T cells through the interleukin-10/Janus kinase 1/signal transducer and activator of transcription 3 pathway, thereby promoting the activation of M2 microglia. These findings suggest that Huanglian Jiedu Decoction, which has heat-clearing and detoxifying properties, can regulate immune homeostasis, inhibit secondary neuroinflammation associated with ischemic stroke, and exert neuroprotective effects. Huanglian Jiedu Decoction may therefore treat ischemic stroke by modulating the interaction between T lymphocytes and microglia, providing a traditional Chinese medicine-based strategy for the treatment of ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: